Les Korsh - Patterson Companies Chief Sec
| PD2 Stock | EUR 29.40 0.40 1.34% |
Insider
Les Korsh is Chief Sec of Patterson Companies
| Age | 53 |
| Phone | 651 686 1600 |
| Web | https://www.pattersoncompanies.com |
Les Korsh Latest Insider Activity
Tracking and analyzing the buying and selling activities of Les Korsh against Patterson Companies stock is an integral part of due diligence when investing in Patterson Companies. Les Korsh insider activity provides valuable insight into whether Patterson Companies is net buyers or sellers over its current business cycle. Note, Patterson Companies insiders must abide by specific rules, including filing SEC forms every time they buy or sell Patterson Companies'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Les Korsh over a month ago Disposition of 1052 shares by Les Korsh of Patterson Companies at 20.76 subject to Rule 16b-3 |
Patterson Companies Management Efficiency
The company has return on total asset (ROA) of 0.0508 % which means that it generated a profit of $0.0508 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1927 %, meaning that it generated $0.1927 on every $100 dollars invested by stockholders. Patterson Companies' management efficiency ratios could be used to measure how well Patterson Companies manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Steven Collis | AmerisourceBergen | 62 | |
| Ola Snow | Cardinal Health | 55 | |
| PharmD Mauch | AmerisourceBergen | 56 | |
| Dawei Ge | Shanghai Pharmaceuticals Holdin | 56 | |
| Silvana Battaglia | AmerisourceBergen | 56 | |
| Jun Zhou | Shanghai Pharmaceuticals Holdin | 50 | |
| Gina Clark | AmerisourceBergen | 66 | |
| James Cleary | AmerisourceBergen | 60 | |
| Jinzhu Chen | Shanghai Pharmaceuticals Holdin | 33 | |
| Lazarus Krikorian | AmerisourceBergen | 58 | |
| Deborah Weitzman | Cardinal Health | N/A | |
| An Li | Shanghai Pharmaceuticals Holdin | 57 | |
| Kathy Gaddes | AmerisourceBergen | 60 | |
| Jinqi Yu | Shanghai Pharmaceuticals Holdin | N/A | |
| Patricia English | Cardinal Health | 43 | |
| Ronald South | Henry Schein | 61 | |
| Christopher Pendergast | Henry Schein | 59 | |
| Mary Scherer | Cardinal Health | N/A | |
| Min Zuo | Shanghai Pharmaceuticals Holdin | 57 | |
| Jiangnan Cai | Shanghai Pharmaceuticals Holdin | 61 | |
| Olga Timoshkina | Henry Schein | N/A | |
Management Performance
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0508 |
Patterson Companies Leadership Team
Elected by the shareholders, the Patterson Companies' board of directors comprises two types of representatives: Patterson Companies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Patterson. The board's role is to monitor Patterson Companies' management team and ensure that shareholders' interests are well served. Patterson Companies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Patterson Companies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin Pohlman, I International | ||
| Kevin Barry, Interim Officer | ||
| Dave Lardy, Chief Officer | ||
| Tim Rogan, Pres Dental | ||
| Les Korsh, Chief Sec | ||
| Andrea Frohning, Chief Officer | ||
| John Wright, VP Relations | ||
| Shivani Kaul, Chief Officer | ||
| Paul Guggenheim, Chief Officer | ||
| Donald Zurbay, Pres CEO |
Patterson Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Patterson Companies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0508 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 3.23 B | |||
| Shares Outstanding | 97.07 M | |||
| Shares Owned By Insiders | 10.62 % | |||
| Shares Owned By Institutions | 84.37 % | |||
| Price To Earning | 18.07 X | |||
| Price To Book | 2.72 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Patterson Stock
When determining whether Patterson Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Patterson Companies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Patterson Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Patterson Companies Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Patterson Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Patterson Stock please use our How to Invest in Patterson Companies guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.